Journal
CRITICAL CARE CLINICS
Volume 29, Issue 3, Pages 411-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccc.2013.03.002
Keywords
Neutropenia; Myelosuppression; Febrile neutropenia; Febrile mucositis; Neutropenic sepsis syndromes; First neutropenic fever; Persistent neutropenic fever; Recrudescent neutropenic fever
Categories
Ask authors/readers for more resources
Neutropenic fever sepsis syndromes are common among patients with cancer who are receiving intensive cytotoxic systemic therapy. Recognition of the syndromes and timely initial antibacterial therapy is critical for survival and treatment success. Outcomes are linked to myeloid reconstitution and recovery from neutropenia, control of active comorbidities, and appropriate treatment of the infections that underlie the sepsis syndrome. Hematologists and oncologists must be clear about the prognosis and treatment goals to work effectively with critical care physicians toward the best outcomes for patients with cancer who develop neutropenic sepsis syndromes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available